Annual EBITDA
$24.25M$2.93M-10.79%
Summary
- Current Value
- As of today, PRVA annual EBITDA is $24.25M, down -10.79% on
- Historical Performance
- PRVA annual EBITDA is up +111.28% over the past 3 years, and up +38.66% over the past 5 years
- All-Time High Comparison
- PRVA annual EBITDA is currently -10.92% below its historical high of $27.22M set on
- 3-Year Low Comparison
- PRVA annual EBITDA is +266.66% above its 3-year low of -$14.55M reached on an earlier date
- Sector Comparison
- PRVA annual EBITDA is higher than 81.27% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $24.25M | -10.8% | +111.3% | +38.7% | +651.5% | |
| Quarterly EBITDA | $17.17M | +125.6% | +601.9% | +90.8% | +151.2% | |
| TTM EBITDA | $37.29M | +83.1% | +203.1% | +64.9% | +445.6% | |
| Price | $24.20 | +19.2% | +12.5% | – | – | |
| PE Ratio | 170.42 | -3.9% | – | – | – | |
| Annual Revenue | $1.74B | +4.7% | +79.7% | +120.8% | +164.1% | |
| Annual EPS | $0.11 | -38.1% | +106.6% | +46.8% | +497.6% | |
| Annual EBIT | $16.98M | -17.8% | +107.8% | +5.7% | +688.0% | |
| Annual Net Income | $17.04M | -18.9% | +108.9% | +114.5% | +506.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $27.18M | -10.8% | |
| 5Y | $27.22M | N/A | -10.9% |
| All | $27.22M | -10.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$14.55M | N/A | +266.7% |
| 5Y | -$214.97M | +111.3% | |
| All | -$214.97M | +111.3% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $24.25M | -10.8% | |
| $27.18M | +286.8% | |
| -$14.55M | +93.2% | |
| -$214.97M | -889.7% |
| Year | Value | Change |
|---|---|---|
| $27.22M | +55.7% | |
| $17.49M | +442.0% | |
| $3.23M | - |
FAQ
What is the current annual EBITDA of PRVA?
As of today, PRVA annual EBITDA is $24.25M
What is 1-year change in PRVA annual EBITDA?
PRVA annual EBITDA is down -10.79% year-over-year
What is 3-year change in PRVA annual EBITDA?
PRVA annual EBITDA is up +111.28% over the past 3 years
How far is PRVA annual EBITDA from its all-time high?
PRVA annual EBITDA is currently -10.92% below its historical high of $27.22M set on December 31, 2020
How does PRVA annual EBITDA rank versus sector peers?
PRVA annual EBITDA is higher than 81.27% of companies in Healthcare sector
When is PRVA next annual earnings release?
The next annual earnings release for PRVA is on
Quarterly EBITDA
$17.17M$11.25M+190.07%
Summary
- Current Value
- As of today, PRVA quarterly EBITDA is $17.17M, up +190.07% on
- Historical Performance
- PRVA quarterly EBITDA is up +125.61% year-over-year, and up +601.87% over the past 3 years
- All-Time High Comparison
- PRVA quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PRVA quarterly EBITDA is +549.36% above its 3-year low of $2.64M reached on
- Sector Comparison
- PRVA quarterly EBITDA is higher than 80.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $17.17M | +190.1% | +125.6% | +601.9% | +90.8% | |
| Annual EBITDA | $24.25M | – | -10.8% | +111.3% | +38.7% | |
| TTM EBITDA | $37.29M | +34.5% | +83.1% | +203.1% | +64.9% | |
| Price | $24.20 | +0.8% | +19.2% | +12.5% | – | |
| PE Ratio | 170.42 | +0.8% | -3.9% | – | – | |
| Quarterly Revenue | $580.42M | +11.4% | +32.5% | +69.3% | +180.2% | |
| Quarterly EPS | $0.05 | +155.0% | +89.7% | +310.0% | -66.2% | |
| Quarterly EBIT | $14.40M | +331.7% | +147.8% | +414.9% | +68.6% | |
| Quarterly Net Income | $9.81M | +198.3% | +146.5% | +1663.8% | -40.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.17M | at high | |
| 3Y | $17.17M | at high | |
| 5Y | $17.17M | at high | |
| All | $17.17M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.92M | +190.1% | |
| 3Y | $2.64M | +549.4% | |
| 5Y | -$192.75M | +108.9% | |
| All | -$192.75M | +108.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PRVA?
As of today, PRVA quarterly EBITDA is $17.17M
What is PRVA quarterly EBITDA most recent change?
PRVA quarterly EBITDA was up +190.07% on September 30, 2025
What is 1-year change in PRVA quarterly EBITDA?
PRVA quarterly EBITDA is up +125.61% year-over-year
How far is PRVA quarterly EBITDA from its all-time high?
PRVA quarterly EBITDA is currently at its all-time high
How does PRVA quarterly EBITDA rank versus sector peers?
PRVA quarterly EBITDA is higher than 80.78% of companies in Healthcare sector
When is PRVA next earnings release?
The next earnings release for PRVA is on
TTM EBITDA
$37.29M$9.56M+34.47%
Summary
- Current Value
- As of today, PRVA TTM EBITDA is $37.29M, up +34.47% on
- Historical Performance
- PRVA TTM EBITDA is up +83.12% year-over-year, and up +203.09% over the past 3 years
- All-Time High Comparison
- PRVA TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PRVA TTM EBITDA is +356.25% above its 3-year low of -$14.55M reached on an earlier date
- Sector Comparison
- PRVA TTM EBITDA is higher than 79.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $37.29M | +34.5% | +83.1% | +203.1% | +64.9% | |
| Annual EBITDA | $24.25M | – | -10.8% | +111.3% | +38.7% | |
| Quarterly EBITDA | $17.17M | +190.1% | +125.6% | +601.9% | +90.8% | |
| Price | $24.20 | +0.8% | +19.2% | +12.5% | – | |
| PE Ratio | 170.42 | +0.8% | -3.9% | – | – | |
| TTM Revenue | $2.04B | +7.5% | +19.0% | +61.1% | +238.5% | |
| TTM EPS | $0.14 | +21.6% | +38.7% | +139.8% | -45.2% | |
| TTM EBIT | $28.21M | +43.8% | +114.4% | +169.3% | +32.9% | |
| TTM Net Income | $24.51M | +31.2% | +75.0% | +160.1% | -9.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $37.29M | at high | |
| 3Y | $37.29M | at high | |
| 5Y | $37.29M | at high | |
| All | $37.29M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.25M | N/A | +53.8% |
| 3Y | -$14.55M | N/A | +356.3% |
| 5Y | -$233.75M | +116.0% | |
| All | -$233.75M | +116.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PRVA?
As of today, PRVA TTM EBITDA is $37.29M
What is PRVA TTM EBITDA most recent change?
PRVA TTM EBITDA was up +34.47% on September 30, 2025
What is 1-year change in PRVA TTM EBITDA?
PRVA TTM EBITDA is up +83.12% year-over-year
How far is PRVA TTM EBITDA from its all-time high?
PRVA TTM EBITDA is currently at its all-time high
How does PRVA TTM EBITDA rank versus sector peers?
PRVA TTM EBITDA is higher than 79.78% of companies in Healthcare sector
When is PRVA next earnings release?
The next earnings release for PRVA is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- PRVA Official Website www.priviahealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1759655/000175965525000110/0001759655-25-000110-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1759655/000175965525000018/0001759655-25-000018-index.htm
- PRVA Profile on Yahoo Finance finance.yahoo.com/quote/PRVA
- PRVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prva